Core Laboratories N.V. (CLB) Misses Q3 EPS by 9c; Guides Q4 EPS, Revs
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mailGet Alerts CLB Hot Sheet
Price: $10.33 +1.08%
EPS Growth %: +45.5%
Financial Fact:
General and Administrative Expense, Excluding Depreciation: 8.41M
Today's EPS Names:
SFBC, KSBI, PVBK, More
EPS Growth %: +45.5%
Financial Fact:
General and Administrative Expense, Excluding Depreciation: 8.41M
Today's EPS Names:
SFBC, KSBI, PVBK, More
Join SI Premium – FREE
Core Laboratories N.V. (NYSE: CLB) reported Q3 EPS of $1.13, $0.09 worse than the analyst estimate of $1.22. Revenue for the quarter came in at $245.43 million versus the consensus estimate of $255.9 million.
Core Laboratories N.v. sees Q4 2012 EPS of $1.10-1.17, versus the consensus of $1.12. Core Laboratories N.v. sees Q4 2012 revenue of $245-250 million, versus the consensus of $252.1 million.
For earnings history and earnings-related data on Core Laboratories N.v. (CLB) click here.
Core Laboratories N.v. sees Q4 2012 EPS of $1.10-1.17, versus the consensus of $1.12. Core Laboratories N.v. sees Q4 2012 revenue of $245-250 million, versus the consensus of $252.1 million.
For earnings history and earnings-related data on Core Laboratories N.v. (CLB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Orion Marine Group (ORN) Tops Q3 EPS by 3c ; Offers Guidance
- UBS AG (UBS) Misses Q3 EPS by 7c; offers outlook
- ONEOK (OKE) Tops Q3 EPS by 63c; raises guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
